Ratings Sharda Cropchem Limited Bombay S.E.

Equities

SHARDACROP

INE221J01015

Market Closed - Bombay S.E. Other stock markets 06:00:47 2024-04-18 am EDT			5-day change	1st Jan Change
359.8 ^INR	-2.41%		-4.49%	-20.60%

Jan. 25	Transcript : Sharda Cropchem Limited, Q3 2024 Earnings Call, Jan 25, 2024
Jan. 24	Sharda Cropchem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation
The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

Historically, the company has been releasing figures that are above expectations.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 171.09 times its estimated earnings per share for the ongoing year.
The valuation of the company is particularly high given the cash flows generated by its activity.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Agricultural Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SHARDA CROPCHEM LIMITED	-20.60%	397M		D+
CORTEVA, INC.	+11.71%	37.41B		C
PHOSAGRO	-.--%	10.92B	-	B+
FMC CORPORATION	-11.09%	7B		A
PI INDUSTRIES LIMITED	+5.68%	6.79B		B-
ICL GROUP LTD	-1.93%	6.02B		B+
OCI N.V.	-5.26%	5.54B		B
YUNNAN YUNTIANHUA CO., LTD.	+34.94%	5.33B		B-
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED	-19.00%	5.16B	-	C-
JORDAN PHOSPHATE MINES CO. PLC	+21.42%	4.53B	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes